BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34842343)

  • 1. Omega 3 fatty acids can reduce early doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia.
    El Amrousy D; El-Afify D; Khedr R; Ibrahim AM
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29496. PubMed ID: 34842343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia.
    Hagag AA; El Shehaby WA; El-Abasy AI; Mabrouk MM
    Infect Disord Drug Targets; 2019; 19(2):133-140. PubMed ID: 30073931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia.
    Hagag AA; Badraia IM; El-Shehaby WA; Mabrouk MM
    J Oncol Pharm Pract; 2020 Sep; 26(6):1397-1406. PubMed ID: 31964219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.
    Elbarbary NS; Ismail EA; Farahat RK; El-Hamamsy M
    Nutrition; 2016 Jan; 32(1):41-7. PubMed ID: 26421385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.
    Asselin BL; Devidas M; Chen L; Franco VI; Pullen J; Borowitz MJ; Hutchison RE; Ravindranath Y; Armenian SH; Camitta BM; Lipshultz SE
    J Clin Oncol; 2016 Mar; 34(8):854-62. PubMed ID: 26700126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial.
    Gupta V; Kumar Singh S; Agrawal V; Bali Singh T
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27308. PubMed ID: 30009543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
    Lipshultz SE; Miller TL; Scully RE; Lipsitz SR; Rifai N; Silverman LB; Colan SD; Neuberg DS; Dahlberg SE; Henkel JM; Asselin BL; Athale UH; Clavell LA; Laverdière C; Michon B; Schorin MA; Sallan SE
    J Clin Oncol; 2012 Apr; 30(10):1042-9. PubMed ID: 22370326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.
    Xue H; Ren W; Denkinger M; Schlotzer E; Wischmeyer PE
    JPEN J Parenter Enteral Nutr; 2016 Jan; 40(1):52-66. PubMed ID: 25888676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
    Foroughinia F; Salamzadeh J; Namazi MH
    Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of fish omega-3 fatty acids on doxorubicin-induced cardiotoxicity in rats.
    Uygur R; Aktas C; Tulubas F; Alpsoy S; Topcu B; Ozen OA
    Hum Exp Toxicol; 2014 Apr; 33(4):435-45. PubMed ID: 24064909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effects of ω-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats.
    Tulubas F; Gurel A; Oran M; Topcu B; Caglar V; Uygur E
    Toxicol Ind Health; 2015 Jul; 31(7):638-44. PubMed ID: 23512535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study.
    Li X; Guo X; Li J; Yuan L; Wang H
    Medicine (Baltimore); 2022 Aug; 101(32):e30000. PubMed ID: 35960075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
    Abbas NAT; Kabil SL
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
    Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
    Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
    Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling cardiac mechanics in doxorubicin-induced cardiotoxicity following childhood acute lymphoblastic leukemia using a combination of cardiac magnetic resonance imaging, cardiopulmonary exercise testing and the CircAdapt model.
    Artz T; Caru M; Curnier D; Abasq M; Krajinovic M; Laverdière C; Sinnett D; Périé D
    J Biomech; 2023 Jun; 154():111616. PubMed ID: 37207545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity evaluation in pediatric patients with acute lymphoblastic leukemia - results of prospective study.
    Radu LE; Ghiorghiu I; Oprescu A; Dorobantu D; Arion C; Colita A
    Med Ultrason; 2019 Nov; 21(4):449-455. PubMed ID: 31765454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
    Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
    Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of carvedilol on adriamycin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.
    El-Shitany NA; Tolba OA; El-Shanshory MR; El-Hawary EE
    J Card Fail; 2012 Aug; 18(8):607-13. PubMed ID: 22858075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.